Navigation Links
eFoodSafety.com Restructures purEffect(TM) Marketing Agreement with CK41
Date:2/12/2009

Company to take an active role in assisting CK41 in launching purEffectTM

SCOTTSDALE, Ariz., Feb. 12 /PRNewswire-FirstCall/ -- eFoodSafety.com, Inc. (OTC Bulletin Board: EFSF), an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products, today announced that it has restructured its Marketing Agreement with Charlston Kentrist 41 Direct, Inc. ("CK41"), the Company's joint venture marketing partner for purEffectTM, a four-step acne treatment system.

eFoodSafety.com believes that a more marketable financial arrangement and greater collaborative effort will enable CK41 to achieve its business financing goals and execute its product marketing plans. Under the terms of the restructuring, eFoodSafety.com will transfer all of its rights to purEffectTM to CK41 for an approximate five percent (5%) equity stake in CK41 with three year warrant rights to purchase up to an additional five percent (5%) equity stake based on the current fully diluted ownership of CK41. Additionally, eFoodSafety.com will receive a two percent (2%) royalty on worldwide purEffectTM adjusted gross sales. The restructured agreement also sets certain performance milestones for CK41 in the launch and marketing of purEffectTM. eFoodSafety.com will have one seat on the CK41 board of directors.

Martin Schmieg, current president and CEO of Freedom2, Inc. and future Chairman and CEO of eFoodSafety.com, commented, "Collectively, eFoodSafety and CK41 can position purEffectTM to reach its market potential in the all-in-one acne treatment solutions market. By pooling our financial and marketing resources, we can overcome the obstacles that have heretofore kept purEffectTM from the market. CK41's business plans are aggressive and rightly so in a market that demands performance and differentiation in order to gain market share. Both CK41 and eFoodSafety are committed to the success of purEffectTM. As such, we plan to do everything possible to help CK41 bring this product to market."

eFoodSafety.com will provide further details on the restructured Marketing Agreement on its monthly investor conference call, scheduled for Tuesday, February 17th at 4:30 p.m. Eastern time.

About eFoodSafety.com, Inc.

eFoodSafety is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercialized healthcare products that address the health needs of consumers worldwide.

About CK41 Direct, Inc.

CK41 Direct, Inc. is a leading producer of direct response infomercial campaigns. Combining 50 years of expertise in network television and direct marketing know-how, the principals and directors of CK41 learned the direct response TV industry from the ground up. This experience has taught CK41 how both conventional and unconventional marketing strategies can excel a direct response television campaign.

Safe Harbor for Public Companies

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

    Contacts:                         Investors:
    Blair Barnes, CFO                 Stephanie Carrington/Amy Glynn
    Freedom2, Inc.                    The Ruth Group
    Ph: 856-354-0707 ext. 201         646-536-7017/7023
    blair@freedom2inc.com             scarrington@theruthgroup.com
                                      aglynn@theruthgroup.com

                                      Press:
                                      Pat Arcand
                                      Arcand & Madison Public Relations
                                      Ph: 617-576-7777
                                      pat@am-pr.com



'/>"/>
SOURCE eFoodSafety.com, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. eFoodSafety.com Engages IridiumGroup to Develop New Brand Identity to Match Future Company Direction
2. eFoodSafety.com Selects Arcand & Madison as Public Relations Counsel and The Ruth Group as Investor Relations Counsel
3. NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure
4. VaxGen Restructures Following Termination of Proposed Merger
5. Pharmos Restructures Operations in Israel
6. Unbelievable Lack Of Marketing Knowledge Forces Doctors To Quit Practice.
7. Syndication Inc. Seeks Director of Marketing for Sy-Med Decompression Centers; BOD Considers Adding a Green Energy New Company Subsidiary to its Ranks
8. Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines
9. Texcel Selects Tiziani Whitmyre for Public Relations, Internet Marketing Services
10. Mindset Marketing Solutions Partners with Platform-A, ValueClick Media, AdRX Media, Datran Media and Morefocus Media
11. ATi Tailored BI and Advanced Predictive Analytics Solutions Improve Marketing Response Rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA ... most comprehensive mental health systems reform legislation in more than fifty years. We ... the commitment of our elected officials to improving mental health services and supports ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a simple, ... and tightening the skin of the face to create more youthful features. While ... very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure that ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... a purchase price of approximately $17.4 million (net of the cash acquired), ... approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is a leading provider ...
(Date:12/7/2016)... Valley, CA (PRWEB) , ... December 07, 2016 , ... ... be used in several ways to restore a more youthful appearance to the face. ... now offer Sculptra, along with a variety of other treatments, to rejuvenate and renew ...
(Date:12/7/2016)... , ... December 07, 2016 , ... They are musicians ... sisters and wives, brothers and fathers, from New England and around the nation. What ... stigma, and are brought together in a beautiful and compelling new photographic exhibit debuting ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. ... health care products and services to office-based dental, animal health ... percent equity investment in Marrodent, one of Poland,s ... approximately $32 million. This transaction was announced on August 30, ... in Poland since 2014, and Marrodent ...
(Date:12/8/2016)... Research and Markets has announced the addition of ... their offering. ... The report provides separate comprehensive analytics for the ... Rest of World. Annual estimates and forecasts are provided ... provided for these markets. Market data and analytics are derived from primary ...
(Date:12/7/2016)... , Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical ... on 37 biosimilar version of Lantus drug in clinical pipeline. Currently 5 ... , Japan , Kenya , ... Germany , China , Slovakia ... 1 & 2 diabetes mellitus. The patent on Lantus expired in 2014. ...
Breaking Medicine Technology: